Yes, just like Prurisol was a lock... Doubt many will jump aboard until after data release... What's the hurry? They've had successful phase 2 trials before and the stock dropped. If this was phase 3 different story...Even with good results will master Leo have a partner or buyer lined up? Will they need an expensive phase 3 in 2022? Some are assuming good data will cure all ills...
News 
Market Data 
Discover 
